Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe

Adeona Appoints George J. Brewer, M.D., Senior Vice President of Research & Development

March 3, 2011 By Bio-Medicine.Org

ANN ARBOR, Mich., March 3, 2011 /PRNewswire/ — Adeona
Pharmaceuticals, Inc. (Amex:
AEN), a developer of innovative medicines for serious central
nervous system diseases, announced today the appointment of George
J. Brewer, M.D., as Senior Vice President of Research &
Development.  Dr. Brewer joins the Adeona management team
after serving as the Chairman of the Company’s Scientific Advisory
Board for seven years.

Dr. Brewer is the Morton S. and Henrietta Sellner Emeritus
Professor of Human Genetics and Internal Medicine at the University
of Michigan.  He was a member of the National Science
Council’s “Committee on Copper in Drinking Water” convened at the
request of the Environmental Protection Agency in 2000 to consider
the issue of what level of copper in drinking water could be
considered “safe.” Dr. Brewer has published over 500 scientific
papers, several books and is the inventor of oral zinc therapy
approved by the Food & Drug Administration (FDA) in 1997, now
standard of care for chronic Wilson’s disease.

“We are pleased that Dr. Brewer, a respected medical innovator
and developer of zinc-based therapies over his career, accepted our
offer to join Adeona’s management team. As the Chairman of our
Scientific Advisory Board, Dr. Brewer provided significant guidance
with regard to our clinical development programs, and we look
forward to his continued valuable contributions in his new role as
Senior Vice President of Research & Development,” stated James
S. Kuo, M.D., M.B.A., Adeona’s Chairman and CEO. “We also
appreciate the condolences received following the passing of our
colleague and friend, David Newsome. While this was an unexpected
loss for the Company, we believe the appointment of Dr. Brewer
positions our clinical development programs for continued
advancement.”

The study coordinators at the three clinical sites conducting
Adeon

‘/>”/>

SOURCE

Related Articles Read More >

The pitch: Cerulean Scientific’s failure-resistant intraventricular catheter
The MIT researcher's implant, LUCID.
MIT researchers design implantable ultrasound-powered drug delivery device to minimize tumor recurrence
A photo of the Paradromics Connexus brain-computer interface on a fingertip.
How Paradromics designed its Connexus brain-computer interface system
An illustration of HITMAN operating in glioblastoma cells.
MIT researchers develop injectable nanodevices that remotely kill brain tumor cells
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 Arrowfly, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe